journal article·2025-08Open access

Apoptotic Bodies Restore NAD and Mitochondrial Homeostasis in Fibroblasts

Shutong Qian, Siya Dai, Chunyi Guo, Wenjun Wang, Jiajia Pang, Yichen Shen, Mingyuan Xu, Jie Hu, Wenguo Cui, Xiaoming Sun, Jinghong Xu

Advanced Science· Volume 12· Issue 29

Abstract

Abstract Fibrotic skin diseases are characterized by excessive fibroblast proliferation and pathological extracellular matrix deposition. As a pivotal coenzyme in cellular energetics, NAD homeostasis perturbation is implicated in fibrosis. Multiple studies have demonstrated the therapeutic potential of mesenchymal stem cells (MSCs) against cutaneous fibrosis, while the specific mechanism remains elusive. Herein, this work finds that although almost all MSCs undergo in situ apoptosis within 24 h post‐subcutaneous administration, MSC‐derived apoptotic bodies (ABs) mediated potent anti‐fibrotic effects. Mechanistically, ABs can restore NAD and mitochondrial homeostasis through NAMPT transfer, FOXO1 deacetylation enhancement, and PINK1/PARKIN‐dependent mitophagy activation. To achieve penetration into the hard matrix of fibrotic skin, permeable apoptotic bodies (pABs) are constructed via metabolic glycoengineering and copper‐free click chemistry techniques. In both keloid xenograft and scleroderma murine models, pABs can significantly penetrate collagen matrix and reduce skin fibrosis. In summary, this research establishes a highly promising strategy for reversing skin fibrosis with hard fibrotic matrix.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Sirtuins and Resveratrol in Medicine · Autophagy in Disease and Therapy · Calcium signaling and nucleotide metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Plastic Surgery The First Affiliated Hospital Zhejiang University School of Medicine 79 Qingchun Road Hangzhou 310003 P. R. China

Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China

Department of Plastic and Reconstructive Surgery Shanghai Ninth People's Hospital Shanghai JiaoTong University School of Medicine 639 Zhi Zao Ju Road Shanghai 200011 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · China Postdoctoral Science Foundation

References (48)

Show source-provided references
1. 10.1016/j.stem.2022.07.00610.1016/j.stem.2022.07.006 ↗
2. 10.1038/s41467-021-24110-y10.1038/s41467-021-24110-y ↗
3. 10.1016/j.redox.2020.10181510.1016/j.redox.2020.101815 ↗
4. 10.1002/adma.20231073110.1002/adma.202310731 ↗
5. 10.20517/2347-9264.2022.0410.20517/2347-9264.2022.04 ↗
6. 10.1038/s44321-024-00081-710.1038/s44321-024-00081-7 ↗
7. 10.1038/s41423-023-00983-510.1038/s41423-023-00983-5 ↗
8. 10.1016/j.biopha.2024.11613310.1016/j.biopha.2024.116133 ↗
9. Siufui H. · Eng. Regener. · 2024 · 5 · 421
10. 10.1038/s41467-021-26834-310.1038/s41467-021-26834-3 ↗
11. 10.1002/jev2.1243410.1002/jev2.12434 ↗
12. 10.1016/j.medj.2024.01.00610.1016/j.medj.2024.01.006 ↗
13. 10.1002/advs.20230655510.1002/advs.202306555 ↗
14. 10.1002/SMMD.2024000510.1002/SMMD.20240005 ↗
15. Mao J. · Research (Wash D C) · 2025 · 23 · 8
16. 10.1038/s41368-024-00293-010.1038/s41368-024-00293-0 ↗
17. Barile L. · Eur. Heart. J. · 2024 · 15
18. 10.1038/s41572-023-00474-x10.1038/s41572-023-00474-x ↗
19. 10.1016/j.actbio.2023.12.02710.1016/j.actbio.2023.12.027 ↗
20. 10.1016/j.carbpol.2021.11796410.1016/j.carbpol.2021.117964 ↗
21. 10.1038/s41419-023-05587-510.1038/s41419-023-05587-5 ↗
22. Sun J. · Exploration · 2025 · 10 · 1002
23. 10.1016/j.cmet.2023.12.00710.1016/j.cmet.2023.12.007 ↗
24. 10.1002/btm2.1062010.1002/btm2.10620 ↗
25. 10.1016/j.scib.2023.07.03010.1016/j.scib.2023.07.030 ↗
26. 10.1111/iwj.1446010.1111/iwj.14460 ↗
27. 10.4252/wjsc.v15.i5.34210.4252/wjsc.v15.i5.342 ↗
28. 10.1016/j.redox.2024.10315910.1016/j.redox.2024.103159 ↗
29. 10.1080/15548627.2023.228793010.1080/15548627.2023.2287930 ↗
30. 10.1038/s41586-019-1150-210.1038/s41586-019-1150-2 ↗
31. 10.1080/15548627.2024.230721510.1080/15548627.2024.2307215 ↗
32. 10.1016/j.devcel.2020.02.01710.1016/j.devcel.2020.02.017 ↗
33. 10.1038/s41392-022-01257-810.1038/s41392-022-01257-8 ↗
34. 10.1016/j.jshs.2020.08.00910.1016/j.jshs.2020.08.009 ↗
35. 10.4062/biomolther.2017.11910.4062/biomolther.2017.119 ↗
36. 10.1186/s12967-023-04241-010.1186/s12967-023-04241-0 ↗
37. 10.1038/s41598-023-49450-110.1038/s41598-023-49450-1 ↗
38. 10.1186/s13287-021-02688-w10.1186/s13287-021-02688-w ↗
39. 10.7150/thno.9448210.7150/thno.94482 ↗
40. 10.3390/cells1204056810.3390/cells12040568 ↗
41. 10.1161/CIRCRESAHA.120.31794310.1161/CIRCRESAHA.120.317943 ↗
42. 10.1136/gutjnl-2017-31424110.1136/gutjnl-2017-314241 ↗
43. 10.1038/nrendo.2015.11710.1038/nrendo.2015.117 ↗
44. 10.1002/adma.20240355710.1002/adma.202403557 ↗
45. 10.1088/2752-5724/ac446b10.1088/2752-5724/ac446b ↗
46. 10.1007/s42765-023-00361-w10.1007/s42765-023-00361-w ↗
47. 10.1016/j.scib.2023.03.03010.1016/j.scib.2023.03.030 ↗
48. 10.1002/art.3827610.1002/art.38276 ↗